Chronic Thromboembolic Pulmonary Hypertension
Last Posted: May 19, 2020
- Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study.
Eichstaedt Christina A, et al. International journal of molecular sciences 2020 5 (9)
- Machine Learning and Deep Neural Network Applications in the Thorax: Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension, Aorta, and Chronic Obstructive Pulmonary Disease.
Remy-Jardin Martine et al. Journal of thoracic imaging 2020 Apr
- [Association between OR2T3 gene and pulmonary arterial hypertension].
Zhang J H, et al. Zhonghua yi xue za zhi 2016 4 (16) 1256-60
- High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension.
Xi Qunying, et al. PloS one 2016 0 (1) e0147396
- Polymorphism of the G protein ß3 subunit gene influences the efficacy of sildenafil in patients with pulmonary hypertension.
Sekine Ayumi, et al. Internal medicine (Tokyo, Japan) 2014 0 (4) 291-7
- Fibrinogen Aa Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance.
Li Ji-Feng, et al. PloS one 2013 0 (7) e69635
- Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension.
Ormiston ML, et al. Circulation 2012 7
- Association of deep vein thrombosis type with clinical phenotype of chronic thromboembolic pulmonary hypertension.
Kantake Masashi, et al. International journal of cardiology 2013 5 (3) 474-7
- Chronic thromboembolic pulmonary hypertension
From NCATS Genetic and Rare Diseases Information Center
- Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene.
Chen Zhiyong, et al. Human genetics 2010 10 (4) 443-52
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.